Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-009534

Chief Operating Officer sold 242,834 shares at an average $16.04 ($3,894,247)

  • Chief Operating Officer acquired 65,834 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN BRUCE D Chief Operating Officer 2019-02-08 Option exercise +11,667 $2.62 $30,568 859,523 D: show line 1 in the form
GIVEN BRUCE D Chief Operating Officer 2019-02-08 Sale −46,167 $15.34 $708,202 813,356 D: show line 2 in the form
GIVEN BRUCE D Chief Operating Officer 2019-02-11 Option exercise +11,667 $2.62 $30,568 825,023 D: show line 3 in the form
GIVEN BRUCE D Chief Operating Officer 2019-02-11 Sale −97,167 $15.66 $1,521,635 727,856 D: show line 4 in the form
GIVEN BRUCE D Chief Operating Officer 2019-02-11 Sale −57,000 $16.48 $939,360 670,856 D: show line 5 in the form
GIVEN BRUCE D Chief Operating Officer 2019-02-12 Option exercise +42,500 $2.01 $85,425 713,356 D: show line 6 in the form
GIVEN BRUCE D Chief Operating Officer 2019-02-12 Sale −42,500 $17.06 $725,050 670,856 D: show line 7 in the form
Open-market sales · 242,834 sh · avg $16.04 · $3,894,247

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
GIVEN BRUCE D Chief Operating Officer 2019-02-08 Option exercise · Stock Option (right to buy) −11,667 531,667 D: show line 8 in the form
GIVEN BRUCE D Chief Operating Officer 2019-02-11 Option exercise · Stock Option (right to buy) −11,667 520,000 D: show line 9 in the form
GIVEN BRUCE D Chief Operating Officer 2019-02-12 Option exercise · Stock Option (right to buy) −42,500 477,500 D: show line 10 in the form
Loading xslF345X03/doc4.xml…